4610128225!

Active Indefinite Delivery Contract Awarded Last action

Contract number
SPE2DP26D0001
Awardee
Awarding agency
Task orders
3 $72,940,000 obligated

Award facts

Opportunity
Combined order value
$72,940,000 Current and potential, with all options
Last date to order 30% complete
IDV ceiling 32% used
$226,440,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Not Available for Competition · 1 offer Only One Source
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Defense Logistics Agency's Medical Supply Chain division awarded a single-award Indefinite Delivery Contract to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. and specialized manufacturer of medical countermeasures based in St. Louis, Missouri. The contract carries a ceiling value of $226.44M with an ultimate completion date of December 4, 2028, and was awarded on December 5, 2025, without small business set-aside designation. Meridian specializes in the development and manufacturing of autoinjector devices and nerve agent antidote treatments, with primary product offerings consisting of DuoDote autoinjectors containing atropine and pralidoxime chloride formulations for treating nerve agent exposure. The company serves as a critical supplier of emergency medical equipment and medical countermeasures to multiple federal agencies responsible for national preparedness, chemical and biological defense, and strategic stockpiling of essential medical products, including the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, the Department of State Bureau of Medical Services, and the U.S. Marshals Service Tactical Operations Division.

Under this indefinite delivery vehicle, the Defense Logistics Agency issued a delivery order valued at $16.41M on December 8, 2025, for antidote treatment products, with performance extending through September 9, 2026. This firm-fixed-price task order was also awarded without set-aside designation and will be performed at Meridian's facility in St. Louis, Missouri. The indefinite delivery structure enables the government to issue multiple delivery orders for medical countermeasures and autoinjector devices as operational requirements and national preparedness needs evolve, while maintaining budgetary control within the established ceiling. This contracting vehicle reflects the government's strategic commitment to maintaining reliable and accessible supplies of nerve agent antidote treatments for military personnel, civilian defense populations, and emergency response capabilities across federal agencies.

Task orders

Task order Ordering agency Obligated Awarded
Antidote treatment - nerve AG SPE2DP26F7931 Medical Supply Chain (DLA) $20,058,500
Antidote treatment SPE2DP26F4183 Medical Supply Chain (DLA) $36,470,000
Antidote treatment SPE2DP26F1088 Medical Supply Chain (DLA) $16,411,500

Quick answers

Who was awarded contract SPE2DP26D0001?

SPE2DP26D0001 was awarded to Meridian Medical Technologies, LLC by Medical Supply Chain (Troop Support) on December 5, 2025.

How much is contract SPE2DP26D0001 worth?

Orders under SPE2DP26D0001 have obligated $72,940,000. SPE2DP26D0001's own ceiling is $226,440,000.

How many orders have been placed under contract SPE2DP26D0001?

3 orders have been placed under SPE2DP26D0001, the latest on July 22, 2026.

Who can order from contract SPE2DP26D0001?

SPE2DP26D0001 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract SPE2DP26D0001 competed?

The extent of competition for SPE2DP26D0001 was not available for competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV